Related Experiment Video
Updated: Jul 4, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Prevalence of atopy in children with chronic constipation
1National Health Service, Pietrelcina (BN) and Trentola Ducenta (CE), Italy.
Insights
This study found chronic constipation (CC) prevalence in children is 1.8%, with no increased atopy association. A cow's milk protein (CMP) elimination diet did not improve refractory constipation.
Area of Science:
- Pediatrics
- Gastroenterology
- Allergy & Immunology
Background:
- Chronic constipation (CC) is a common pediatric issue.
- Atopy, a predisposition to allergic diseases, is prevalent in childhood.
- The role of cow's milk protein (CMP) in pediatric constipation is debated.
Purpose of the Study:
- To determine the prevalence of CC in a general pediatric population.
- To investigate the association between CC and atopy in children.
- To assess the efficacy of a CMP elimination diet for refractory CC.
Main Methods:
- A 3-month cross-sectional study of 5113 children (0-12 years) for CC prevalence.
- Evaluation of atopy in 69 constipated children (6 months-6 years) and matched controls using questionnaires and allergy testing.
- A 4-week CMP elimination diet trial for 11 children with refractory CC.
Main Results:
- CC prevalence was 1.8% in the overall study population.
- Atopy prevalence in constipated children (17.3%) was similar to controls (18.8%).
- No improvement in refractory CC was observed after a 4-week CMP elimination diet.
Conclusions:
- Atopy prevalence is not higher in children with CC compared to the general population.
- Cow's milk protein allergy does not appear to be a significant factor in refractory pediatric constipation.
Objectives:
To evaluate the prevalence of chronic constipation (CC) in unselected children, its association with atopy and the efficacy of a cow's milk protein (CMP) elimination diet on refractory constipation.
Study Design:
The study was conducted by six primary care paediatricians, serving a population of 5113 children aged from birth through to 12 years; only 2068 children were 6 months to 6 years. During a 3-month period, prevalence of CC was determined for the entire study population, ages 0-12 years. In the second part of the study, all patients aged 6 months to 6 years with CC, and age- and sex-matched controls, were evaluated for atopy and its association with CC. A questionnaire was completed including personal and family history of atopy and bowel-movement characteristics. Patients were tested for atopy by specific serum IgE and/or skin-prick tests. Constipated patients, refractory to osmotic laxatives, underwent a 4-week CMP elimination diet.
Results:
91 (1.8%) children had CC, and 69 (3.3%) of the 6 months to 6 years age group fell into the atopy study age range. All 69 constipated children (mean age 34.9 (18.0) months) and 69 controls completed the questionnaire. Twelve of the 69 constipated children (17.3%) and 13 out of the 69 control children (18.8%) had a diagnosis of atopy. Eleven out of 69 (15.9%) constipated children were refractory to constipation treatment, and three (27.3%) of these had atopy. The 4-week trial of dietary elimination did not result in improvement in any of these 11 children.
Conclusions:
In our study group, prevalence of atopy among children with CC is similar to that in the general population. The level of refraction of CC does not seem to be related to cow's milk allergy.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS
Asthma III: Clinical Manifestations
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Asthma-III: Symptoms and Complications
Classification of Asthma
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features